EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cardiolipin Dysregulation in Glioblastoma—Effects on Mitochondrial Function Tumor Cell Death and Sensitivity to Mitochondria‐Targeting Drugs

Jean-Jacques Hunter, Luis Del Valle, Francesca Peruzzi, Krzysztof Reiss iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Jean-Jacques Hunter und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Tulane University, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Glioblastoma, Cardiolipins, Mitochondria, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological systems do not exist in isolation. Analogous to the intricate design of a spider web, the metabolic adaptations propagated by glioblastoma cells are interlaced, creating a “defense mechanism” that increases the likelihood of mutagenesis and proliferation, while mitigating stress‐induced tumor cell death and immune evasion. Previous studies have observed the role of cardiolipin (CL) in the electron transport chain (ETC) function and several other intracellular signaling pathways. Our review provides a synopsis of the existing knowledge about CL in glioblastoma and its complex relationship with metabolic reprogramming at the subcellular level. Through a meticulous examination of CL defects due to its biogenesis and stress‐induced modifications, we seek to elucidate the multifaceted connections between aberrant CL variants and the metabolic alterations that underlie glioblastoma progression. A comprehensive grasp of these mechanisms could provide future direction in designing chemotherapeutic agents that selectively target glioblastoma, are less harmful to normal cells, and therefore, may extend patient survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaCardiolipinsMitochondriaAntineoplastic AgentsBrain NeoplasmsHumansCell DeathAnimalsSignal Transduction

Stichwörter der Autor:innen

cardiolipinelection transport Chainglioblastomamitochondria

Substanzen

CardiolipinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Neuroscience, Tulane University, New Orleans, Louisiana, USA.
  • Department of Interdisciplinary Oncology, Stanley S Scott Cancer Center, LSU Health Sciences Center, New Orleans, Louisiana, USA.
  • Department of Pathology, Stanley S Scott Cancer Center, LSU Health Sciences Center, New Orleans, Louisiana, USA.
  • Department of Medicine, Stanley S Scott Cancer Center, LSU Health Sciences Center, New Orleans, Louisiana, USA.

ORCID-Profile: Krzysztof Reiss

Förderung

  • NCI NIH HHS

Zitieren

APA

Hunter, J. J., Del Valle, L., Peruzzi, F., & Reiss, K. (2025). Cardiolipin Dysregulation in Glioblastoma—Effects on Mitochondrial Function Tumor Cell Death and Sensitivity to Mitochondria‐Targeting Drugs. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70045

Vancouver

Hunter JJ, Del Valle L, Peruzzi F, Reiss K. Cardiolipin Dysregulation in Glioblastoma—Effects on Mitochondrial Function Tumor Cell Death and Sensitivity to Mitochondria‐Targeting Drugs. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70045

BibTeX
@article{Hunter2025,
  author = {Hunter, Jean-Jacques and Del Valle, Luis and Peruzzi, Francesca and Reiss, Krzysztof},
  title = {Cardiolipin Dysregulation in Glioblastoma—Effects on Mitochondrial Function Tumor Cell Death and Sensitivity to Mitochondria‐Targeting Drugs},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70045}
}
Kostenlos starten →